Q2 2018

Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001144204-18-044727

Q2 2018 · 10-Q

Revenue

$278.00K

+215.9% vs Q2 2017

Net Income

-$21.18M

N/M vs Q2 2017

EPS Diluted

-$0.06

N/M vs Q2 2017

Operating Income-$20,354,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2018	Q2 2017	Q2 2016	Q2 2015
Revenue	$278.00K	$88.00K	$157.00K	$391.00K
Net Income	-$21.18M	-$10.25M	-$14.18M	-$66.85M
EPS Diluted	-$0.06	-$0.05	-$0.16	-$0.88

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR